Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D00YXU
|
|||
Former ID |
DIB000049
|
|||
Drug Name |
CCX-025
|
|||
Synonyms |
CCX-807; CCR9 chemokine receptor-targeting therapeutic (gastrointestinal diseases), ChemoCentryx
Click to Show/Hide
|
|||
Indication | Crohn disease [ICD-11: DD70; ICD-10: K50, K50.9; ICD-9: 555] | Phase 1 | [1] | |
Company |
ChemoCentryx Inc
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | C-C chemokine receptor type 9 (CCR9) | Target Info | Antagonist | [2], [3] |
KEGG Pathway | Cytokine-cytokine receptor interaction | |||
Chemokine signaling pathway | ||||
Intestinal immune network for IgA production | ||||
Panther Pathway | Inflammation mediated by chemokine and cytokine signaling pathway | |||
Reactome | Chemokine receptors bind chemokines | |||
G alpha (i) signalling events | ||||
WikiPathways | GPCRs, Class A Rhodopsin-like | |||
Peptide GPCRs | ||||
GPCR ligand binding | ||||
GPCR downstream signaling |
References | Top | |||
---|---|---|---|---|
REF 1 | Clinical pipeline report, company report or official report of ChemoCentryx Inc. | |||
REF 2 | Targeting T-cell migration in inflammatory bowel disease. J Intern Med. 2012 Nov;272(5):411-29. | |||
REF 3 | GSK-1605786, a selective small-molecule antagonist of the CCR9 chemokine receptor for the treatment of Crohn's disease. IDrugs. 2010 Jul;13(7):472-81. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.